Long-term treatment with a Chinese herbal formula, Sheng-Mai-San, improves cardiac contractile function in aged rats: The role of Ca2+ homeostasis

Rejuvenation Research

Volumn 11, Issue 6, 2008, Pages 991-1000

  Zhang, Guang Qin ^a   Wang, Hui ^b   Liu, Wen Tao ^c   Dong, Hang ^b   Fong, Wang Fun ^b   Tang, Li Min ^d   Xiong, Yun Hua ^d   Yu, Zhi Ling ^b   Ko, Kam Ming ^e  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Laboratory for Quality Control   (China)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CALCIUM CHANNEL L TYPE; CHINESE DRUG; FRUCTUS SCHISANDRAE CHINENSIS EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; OPHIOPOGON ROOT; PLANT EXTRACT; RYANODINE RECEPTOR; SHENG MAI SAN; STRONTIUM; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL ISOLATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GINSENG; HEART CELL CULTURE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; MEMBRANE CURRENT; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; SARCOPLASMIC RETICULUM; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGING; ANIMALS; CALCIUM; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; HOMEOSTASIS; MICROSCOPY, CONFOCAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

RATTUS;

EID: 58149240139     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0771     Document Type: Article

References (40)

1. Zhang YS. Yixue Qiyuan. Beijing, People's Medical Publishing House, 1995.
2. Chinese pharmacopoeia commission. Pharmacopoeia of the People's Republic of China. Beijing, People's Medical Publishing House, 2005.
3. Huang JL, Meng DS. Clinical application of Shengmai injection in cardiovascular diseases. Fujian Zhong Yi Yao 2007;38:61-62.
4. Zhang JZ. The progress of study on the application of shengmaisan in the treatment of cardiovascular diseases. Henan Zhong Yi 2007;27:80-82.
5. Yu LH. Research headway of the Shengmaisan on treating the chronic congestive heart failure. J Med Sci Yanbian Univ 2004;27:152-156.
6. Zeng XH, Zeng XG. Injection Sheng Mei therapy for chronic heart failure and Ginsenoside re plasma concentration monitoring by HPLC. J Chengdu Univ 2004;23:1-8.
7. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-467.
8. Kitzman DW. Diastolic heart failure in the elderly. Heart Fail Rev 2002;7:17-27.
9. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997;96:2755-2757.
10. Haan MN, Selby JV, Quesenberry Jr CP, Schmittdiel JA, Fireman BH, Rice DP. The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991. J Am Geriatr Soc 1997;45:667-674.
11. Zaugg C, Buser P. When calcium turns arrhythmogenic: intracellular calcium handling during the development of hypertrophy and heart failure. Croat Med J 2001;42:24-32.
12. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol 1985;85:247-289.
13. 2+ sparks: Elementary events underlying excitation-contraction coupling in heart muscle. Science 1993;262:740-744.
14. 2+-channel currents in cardiac cells. Science 1995;268:1042-1045.
15. You JS, Huang HF, Chang YL, Lee YS. Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats. Am J Chin Med 2006;34: 295-305.
16. Ma L, Wang HH, Xie QM. A study on the long-term toxicity of shengmaiyin in rats. Zhejiang Prev Med 2003:15: 15-17.
17. Xu SY, Bian RL, Chen X. Experimental Methodology of Pharmacology. In: Hu, Y., Shen, GS, Fang, DC, ed. Method for Measuring Blood Flow and Hemodynamics, 3rd ed. Beijing, People's Medical Publishing House, 1989, pp. 976-982.
18. Zhang GQ, Hao XM, Zhou PA, Wu CH. Effect of paeonol on L-type calcium channel in rat ventricular myocytes. Methods Find Exp Clin Pharmacol 2003;25:283-285.
19. Ferrier GR, Smith RH, Howlett SE. Calcium sparks in mouse ventricular myocytes at physiological temperature. Am J Physiol 2003;285:H1495-H1505.
20. 2+]i transient in rat cardiac myocytes. Am J Physiol 2004;287:H1987-1993.
21. 2+ sparks in resting cardiac myocytes. Sci China (C Life Sci) 2004;47:31-37.
22. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ, Rosenzweig A. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 1998;95:5251-5256.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
24. Yu Z, Feng D, Liang C. Pairwise interactions of the six human MCM protein subunits. J Mol Biol 2004;340:1197-206.
25. Schotten U, Schumacher C, Conrads V, Braun V, Schöndube F, Voss M, Hanrath P. Calcium-sensitivity of the SR calcium release channel in failing and nonfailing human myocardium. Basic Res Cardiol 1999;94:145-151.
26. Cheng H, Song LS, Shirokova N, González A, Lakatta EG, Ríos E, Stern MD. Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys J 1999;76:601-617.
27. 2+ sparks and gating properties of ryanodine receptors in aged cardiomyocytes. Cell Calcium 2005;37:583-591.
28. Rozenberg S, Tavernier B, Riou B, Swynghedauw B, Page CL, Boucher F, Leiris J, Besse S. Severe impairment of ventricular compliance accounts for advanced age-associated hemodynamic dysfunction in rats. Exp Gerontol 2006;41:289-295.
29. Pacher P, Mabley JG, Liaudet L, Evgenov OV, Marton A, Hasko G, Kollai M, Szabo C. Left ventricular pressure-volume relationship in a rat model of advanced a ging-associated heart failure. Am J Physiol 2004;287:H2132-H2137.
30. Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MW. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol 2004;96:822-828.
31. Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 1993;27:1968-1977.
32. Lim CC, Apstein CS, Colucci WS, Liao R. Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to the senescent mouse cardiomyocyte. J Mol Cell Cardiol 2000;32:2075-2082.
33. Wahr PA, Michele DE, Metzger JM. Effects of aging on single cardiac myocyte function in Fischer 344 x Brown Norway rats. Am J Physiol 2000;279:H559-H565.
34. Taffet GE, Tate CA. Ca-ATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats. Am J Physiol 1993;264:H1609-H1614.
35. Tate CA, Helgason T, Hyek MF, McBride RP, Chen M, Richardson MA, Taffet GE. SERCA2a and mitochondrial cytochrome oxidase expression are increased in hearts of exercise-trained old rats. Am J Physiol 1996;271:H68-H72.
36. DelPrincipe F, Egger M, Niggli E. Calcium signalling in cardiac muscle: refractoriness revealed by coherent activation. Nat Cell Biol 1999;1:323-329.
37. 2+ channels on early after-depolarizations. Biophys J 2005;88:85-95.
38. Keller M, Pignier C, Egger M, Niggli E. F90927: a new member in the class of cardioactive steroids. Cardiovasc Drug Rev 2007;25:210-220.
39. del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK, Hajjar RJ. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci USA 2004;101:5622-5627.
40. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd ed. Dordrecht, Germany, Kluwer, 2001.